Review



primary antibodies against nlrp3  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Proteintech primary antibodies against nlrp3
    Primary Antibodies Against Nlrp3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1647 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/NLRP3+Antibody/pm41521014-65-0-4
    Average 96 stars, based on 1647 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: Inhibition of Caspase-1-mediated pyroptosis promotes osteogenic differentiation, offering a therapeutic target for osteoporosis.
    Article Snippet: Background: Pyroptosis, an emerging inflammatory form of cell death, has been previously demonstrated to stimulate a massive inflammatory response, thus hindering the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).. Nevertheless, the impact of pyroptosis in thwarting osteogenic differentiation and exacerbating the advancement of osteoporosis (OP) remains enigmatic.. Methods: We evaluated the expression levels of pyroptosis-associated indicators, including NOD-like receptor family pyrin domain-containing protein 3 (NLRP3), CASPASE-1, IL-1β, and IL-18, in specimens obtained from femoral heads of OP patients, as well as in an ovariectomy-induced mouse model of OP.

    Membrane:

    Article Title: miR-23a-5p Alleviates Gouty Inflammation by Targeting Interleukin-17A and Inhibiting NLR Family Pyrin Domain Containing 3 Inflammasome Activation
    Article Snippet: .. Next, primary antibodies against NLRP3 (1 : 1000, no. 19771-1-AP; Proteintech, China), caspase-1 (1 : 1000, no. 22915-1-AP; Proteintech, China), IL-18 (1 : 1000, no. A1115; ABclonal, Wuhan, China), IL-17A (1 : 1000, no. ab218013; Abcam, UK), and β-actin (1 : 100000, no. AC026; ABclonal, Wuhan, China) were used to incubate with the membrane overnight at 4oC, followed by incubation with goat anti-rabbit IgG H&L (1 : 5000, Abcam, no. ab6721, UK) or goat anti-mouse IgG H&L (1 : 5000; Abcam, no. ab6789, UK) for 1 hour. .. Enhanced chemiluminescence detection kits (Proteintech, China) and ImageJ software (Bethesda, MD, USA) were used to detect protein expression.

    Incubation:

    Article Title: miR-23a-5p Alleviates Gouty Inflammation by Targeting Interleukin-17A and Inhibiting NLR Family Pyrin Domain Containing 3 Inflammasome Activation
    Article Snippet: .. Next, primary antibodies against NLRP3 (1 : 1000, no. 19771-1-AP; Proteintech, China), caspase-1 (1 : 1000, no. 22915-1-AP; Proteintech, China), IL-18 (1 : 1000, no. A1115; ABclonal, Wuhan, China), IL-17A (1 : 1000, no. ab218013; Abcam, UK), and β-actin (1 : 100000, no. AC026; ABclonal, Wuhan, China) were used to incubate with the membrane overnight at 4oC, followed by incubation with goat anti-rabbit IgG H&L (1 : 5000, Abcam, no. ab6721, UK) or goat anti-mouse IgG H&L (1 : 5000; Abcam, no. ab6789, UK) for 1 hour. .. Enhanced chemiluminescence detection kits (Proteintech, China) and ImageJ software (Bethesda, MD, USA) were used to detect protein expression.



    Similar Products

    primary antibodies against nlrp3  (Affinity Biosciences)
    86
    Affinity Biosciences primary antibodies against nlrp3
    Primary Antibodies Against Nlrp3, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/anti+nlrp3/pm42259094-94-22-57
    Average 86 stars, based on 1 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    primary antibodies against nlrp3  (Cell Signaling Technology Inc)
    98
    Cell Signaling Technology Inc primary antibodies against nlrp3
    Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of <t>NLRP3,</t> Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.
    Primary Antibodies Against Nlrp3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/NLRP3+Rabbit+mAb/pmc12907102-312-0-10
    Average 98 stars, based on 1 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    98/100 stars
    		  Buy from Supplier
    primary antibodies against nlrp3  (Wanleibio)
    86
    Wanleibio primary antibodies against nlrp3
    Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of <t>NLRP3,</t> Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.
    Primary Antibodies Against Nlrp3, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/anti+nlrp3/pm41539751-38-0-11
    Average 86 stars, based on 1 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    primary antibodies against nlrp3  (Proteintech)
    96
    Proteintech primary antibodies against nlrp3
    Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of <t>NLRP3,</t> Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.
    Primary Antibodies Against Nlrp3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/NLRP3+Antibody/pm41521014-65-0-4
    Average 96 stars, based on 1 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    primary antibody against nlrp3 wl02635  (Wanleibio)
    86
    Wanleibio primary antibody against nlrp3 wl02635
    Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of <t>NLRP3,</t> Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.
    Primary Antibody Against Nlrp3 Wl02635, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/anti+nlrp3/pm41205567-61-0-8
    Average 86 stars, based on 1 article reviews
    primary antibody against nlrp3 wl02635 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    primary antibodies against nlrp3  (Cusabio)
    94
    Cusabio primary antibodies against nlrp3
    Regulation of <t>NLRP3</t> inflammasome activation by antibiotic‐loaded bone cement (ALBC). (a) Schematic diagram of NLRP3 inflammasome activation; (b) immunohistochemistry detection of NLRP3 and Caspase‐1 expression in full‐thickness skin tissue surrounding the wound edge in mice; (c, d) western blot analysis of Pro‐Caspase‐1 and cleaved Caspase‐1 expression in cells; (e) IF detection of NLRP3 and apoptosis‐associated speck‐like protein containing a CARD (ASC) co‐localization. N = 6; cell experiments were repeated three times; *** p < 0.001 between groups. ALBC‐H, high‐dose ALBC; ALBC‐L, low‐dose ALBC; ALBC‐M, medium‐dose ALBC; HG, high‐glucose.
    Primary Antibodies Against Nlrp3, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+nlrp3/NLRP3/pmc12617559-77-0-8
    Average 94 stars, based on 1 article reviews
    primary antibodies against nlrp3 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.

    Journal: Bioactive Materials

    Article Title: 3D-MSCs apoptotic bodies-integrated conductive hydrogel mitigates spinal cord injury via immunoregulation and alleviating neuronal pyroptosis

    doi: 10.1016/j.bioactmat.2026.01.043

    Figure Lengend Snippet: Composite hydrogel promotes the polarization of BV2 cells to M2 types and alleviates PC12 cell pyroptosis in vitro inflammatory environment. (A) Representative western blots showing protein expression of iNOS and Arg-1 in each group, β-actin was utilized as a loading control. (B) Quantitative analysis of relative expression of iNOS and Arg-1. (C) Representative immunofluorescence images of CD68 positive and iNOS positive BV2 cells (scale bar: 20 μm). (D) Representative immunofluorescence images of CD68 positive and Arg-1 positive BV2 cells (scale bar: 20 μm). (E, F) Quantitative analysis of relative fluorescence intensity of iNOS and Arg-1. (G) Representative western blots showing the expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein associated with pyroptosis, β-actin was utilized as a loading control. (H) PI staining of PC12 cells in each group (scale bar, 100 μm). (I) Quantitative analysis of PI staining of PC12 cells (n = 3). (J) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.

    Article Snippet: Primary antibodies against NLRP3 (cat. no. 15101) were obtained from Cell Signaling Technology (Beverly, Massachusetts, USA).

    Techniques: In Vitro, Western Blot, Expressing, Control, Immunofluorescence, Fluorescence, Staining, Comparison

    The composite hydrogel inhibits post-SCI pyroptosis in neurons. (A) Immunofluorescence images of residual neurons existing in the anterior horn of the spinal cord (scale bar, 500 μm and 200 μm). (B) Immunofluorescence image of Caspase-1 expression of neurons 3 days after SCI (scale bar, 20 μm). (C) Quantitative analysis of relative fluorescence intensity of Caspase-1 protein expression in neurons within the specified groups (n = 3). (D) Immunofluorescence image of GSDMD-N expression of neurons 3 days after SCI (scale bar, 20 μm). (E) Quantitative analysis of relative fluorescence intensity of GSDMD-N protein expression in neurons within the specified groups (n = 3). (F) Representative western blots showing the expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein 3 days after SCI, GAPDH was utilized as a loading control. (G) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.

    Journal: Bioactive Materials

    Article Title: 3D-MSCs apoptotic bodies-integrated conductive hydrogel mitigates spinal cord injury via immunoregulation and alleviating neuronal pyroptosis

    doi: 10.1016/j.bioactmat.2026.01.043

    Figure Lengend Snippet: The composite hydrogel inhibits post-SCI pyroptosis in neurons. (A) Immunofluorescence images of residual neurons existing in the anterior horn of the spinal cord (scale bar, 500 μm and 200 μm). (B) Immunofluorescence image of Caspase-1 expression of neurons 3 days after SCI (scale bar, 20 μm). (C) Quantitative analysis of relative fluorescence intensity of Caspase-1 protein expression in neurons within the specified groups (n = 3). (D) Immunofluorescence image of GSDMD-N expression of neurons 3 days after SCI (scale bar, 20 μm). (E) Quantitative analysis of relative fluorescence intensity of GSDMD-N protein expression in neurons within the specified groups (n = 3). (F) Representative western blots showing the expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N, and IL-18 protein 3 days after SCI, GAPDH was utilized as a loading control. (G) Quantitative analysis of relative expression of NLRP3, Caspase-1, IL-1β, ASC, GSDMD-N and IL-18 (n = 3). The data are presented as the means ± SEMs (n = 3); ∗p < 0.05, indicates significant differences; ns, is not significant. Statistical analysis was performed using two-way ANOVA followed by Tukey's multiple comparison test.

    Article Snippet: Primary antibodies against NLRP3 (cat. no. 15101) were obtained from Cell Signaling Technology (Beverly, Massachusetts, USA).

    Techniques: Immunofluorescence, Expressing, Fluorescence, Western Blot, Control, Comparison

    Regulation of NLRP3 inflammasome activation by antibiotic‐loaded bone cement (ALBC). (a) Schematic diagram of NLRP3 inflammasome activation; (b) immunohistochemistry detection of NLRP3 and Caspase‐1 expression in full‐thickness skin tissue surrounding the wound edge in mice; (c, d) western blot analysis of Pro‐Caspase‐1 and cleaved Caspase‐1 expression in cells; (e) IF detection of NLRP3 and apoptosis‐associated speck‐like protein containing a CARD (ASC) co‐localization. N = 6; cell experiments were repeated three times; *** p < 0.001 between groups. ALBC‐H, high‐dose ALBC; ALBC‐L, low‐dose ALBC; ALBC‐M, medium‐dose ALBC; HG, high‐glucose.

    Journal: Bioengineering & Translational Medicine

    Article Title: Engineering macrophage phenotype switching via nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome inhibition: A translational approach using antibiotic cement for diabetic foot ulcers

    doi: 10.1002/btm2.70073

    Figure Lengend Snippet: Regulation of NLRP3 inflammasome activation by antibiotic‐loaded bone cement (ALBC). (a) Schematic diagram of NLRP3 inflammasome activation; (b) immunohistochemistry detection of NLRP3 and Caspase‐1 expression in full‐thickness skin tissue surrounding the wound edge in mice; (c, d) western blot analysis of Pro‐Caspase‐1 and cleaved Caspase‐1 expression in cells; (e) IF detection of NLRP3 and apoptosis‐associated speck‐like protein containing a CARD (ASC) co‐localization. N = 6; cell experiments were repeated three times; *** p < 0.001 between groups. ALBC‐H, high‐dose ALBC; ALBC‐L, low‐dose ALBC; ALBC‐M, medium‐dose ALBC; HG, high‐glucose.

    Article Snippet: Primary antibodies against NLRP3 (CSB‐ PA209407 , 1:100, Cusabio) and Caspase‐1 (CSB‐ PA001227 , 1:100, Cusabio) were diluted according to the manufacturer's instructions, applied to the slides, and incubated overnight at 4°C.

    Techniques: Activation Assay, Immunohistochemistry, Expressing, Western Blot

    Role of the NLRP3 inflammasome in the therapeutic effect of antibiotic‐loaded bone cement (ALBC) in diabetic foot ulcer (DFU) mice. (a) Schematic diagram of the treatment protocol in which diabetic foot ulcer (DFU0 mice received high‐dose antibiotic‐loaded bone cement [ALBC‐H] in combination with the NLRP3 activator Nigericin or the inhibitor MCC950); (b) wound healing rates on Days 7 and 14 in each group; (c) immunohistochemistry analysis of NLRP3 and Caspase‐1 expression in skin tissues from each group; (d) enzyme‐linked immunosorbent assay analysis of IL‐1β and IL‐18 cytokine levels; (e) immunofluorescence detection of TNF‐α, iNOS, CD206, and CD163 protein expression in mouse skin tissues. N = 6; * p < 0.05, ** p < 0.01, *** p < 0.001 between groups.

    Journal: Bioengineering & Translational Medicine

    Article Title: Engineering macrophage phenotype switching via nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome inhibition: A translational approach using antibiotic cement for diabetic foot ulcers

    doi: 10.1002/btm2.70073

    Figure Lengend Snippet: Role of the NLRP3 inflammasome in the therapeutic effect of antibiotic‐loaded bone cement (ALBC) in diabetic foot ulcer (DFU) mice. (a) Schematic diagram of the treatment protocol in which diabetic foot ulcer (DFU0 mice received high‐dose antibiotic‐loaded bone cement [ALBC‐H] in combination with the NLRP3 activator Nigericin or the inhibitor MCC950); (b) wound healing rates on Days 7 and 14 in each group; (c) immunohistochemistry analysis of NLRP3 and Caspase‐1 expression in skin tissues from each group; (d) enzyme‐linked immunosorbent assay analysis of IL‐1β and IL‐18 cytokine levels; (e) immunofluorescence detection of TNF‐α, iNOS, CD206, and CD163 protein expression in mouse skin tissues. N = 6; * p < 0.05, ** p < 0.01, *** p < 0.001 between groups.

    Article Snippet: Primary antibodies against NLRP3 (CSB‐ PA209407 , 1:100, Cusabio) and Caspase‐1 (CSB‐ PA001227 , 1:100, Cusabio) were diluted according to the manufacturer's instructions, applied to the slides, and incubated overnight at 4°C.

    Techniques: Immunohistochemistry, Expressing, Enzyme-linked Immunosorbent Assay, Immunofluorescence

    Effects of antibiotic‐loaded bone cement on wound tissues of diabetic foot ulcer (DFU) patients. (a) Immunofluorescence detection of M1 and M2 macrophage phenotype markers in DFU patient wound tissues; (b) immunohistochemistry analysis of NLRP3 and Caspase‐1 expression in DFU patient wound tissues. N = 3; *** p < 0.001 between groups.

    Journal: Bioengineering & Translational Medicine

    Article Title: Engineering macrophage phenotype switching via nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome inhibition: A translational approach using antibiotic cement for diabetic foot ulcers

    doi: 10.1002/btm2.70073

    Figure Lengend Snippet: Effects of antibiotic‐loaded bone cement on wound tissues of diabetic foot ulcer (DFU) patients. (a) Immunofluorescence detection of M1 and M2 macrophage phenotype markers in DFU patient wound tissues; (b) immunohistochemistry analysis of NLRP3 and Caspase‐1 expression in DFU patient wound tissues. N = 3; *** p < 0.001 between groups.

    Article Snippet: Primary antibodies against NLRP3 (CSB‐ PA209407 , 1:100, Cusabio) and Caspase‐1 (CSB‐ PA001227 , 1:100, Cusabio) were diluted according to the manufacturer's instructions, applied to the slides, and incubated overnight at 4°C.

    Techniques: Immunofluorescence, Immunohistochemistry, Expressing